Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
16,070,639
-
Share change
-
-1,604,271
-
Total reported value
-
$42,548,008
-
Price per share
-
$2.65
-
Number of holders
-
49
-
Value change
-
-$4,202,884
-
Number of buys
-
11
-
Number of sells
-
22
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q1 2019
As of 31 Mar 2019,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,070,639 shares.
The largest 10 holders included
BB BIOTECH AG, BVF INC/IL, Omega Fund Management, LLC, INTERWEST VENTURE MANAGEMENT CO, FRAZIER MANAGEMENT LLC, Aisling Capital LLC, Opaleye Management Inc., VANGUARD GROUP INC, ALETHEA CAPITAL MANAGEMENT, LLC, and Monashee Investment Management LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.